Celltrion’s Avtozma Biosimilar Added to U.S. Preferred Drug List
Seoul: Celltrion Inc., a major South Korean biopharmaceutical company, announced that its biosimilar for autoimmune diseases has been added to the preferred drug list of
Seoul: Celltrion Inc., a major South Korean biopharmaceutical company, announced that its biosimilar for autoimmune diseases has been added to the preferred drug list of
Seoul: South Korean companies, particularly those involved in the global artificial intelligence (AI) supply chain such as semiconductor manufacturers, are expected to experience continued demand
Shanghai: Musinsa Co., a South Korean fashion and retail platform company, announced plans to open its first overseas outlet in China as part of its
Washington: Chung Yong-jin, chairman of South Korean retail conglomerate Shinsegae Group, has left for the United States to attend a Christmas dinner hosted by U.S.
Guangzhou: Hyundai Motor Group has clinched a significant order to supply over 200 hydrogen-powered buses to Guangzhou, marking the largest single hydrogen bus procurement deal
Sejong: South Korea’s newly launched media watchdog announced plans to introduce a transparency center next year aimed at tackling fake news circulating online. The Korea
The “Korean News Digest” website serves as a comprehensive hub for news, catering to an expansive range of categories including General, Business, Science, Fashion, Medical, Games, Governance, and Press Releases.
Â
The “Korean News Digest” website serves as a comprehensive hub for news, catering to an expansive range of categories including General, Business, Science, Fashion, Medical, Games, Governance, and Press Releases.
This diverse coverage showcases the site’s commitment to broad-spectrum news dissemination, aiming to engage a diverse audience with varied interests across multiple disciplines.